But because the court dismissed the case on standing, the decision does not prevent other anti-abortion advocates from filing another lawsuit against the FDA. “The plaintiffs have sincere legal, moral, ideological, and policy objections to elective abortion and to FDA’s relaxed regulation of mifepristone,” Justice Brett M. Kavanaugh wrote for the unanimous court. “But under Article III of the Constitution, those kinds of objections alone do not establish a justiciable case or controversy in federal court. Here, the plaintiffs have failed to demonstrate that FDA’s relaxed regulatory requirements likely would cause them to suffer an injury in fact. Biden administration Solicitor Gen. Elizabeth B. Prelogar appealed to the Supreme Court and called the case a first.

Source: Los Angeles Times June 13, 2024 14:54 UTC